PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.34%
Revenue growth under 50% of QCOM's 3.04%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.45%
Gross profit growth under 50% of QCOM's 33.00%. Michael Burry would be concerned about a severe competitive disadvantage.
-9.38%
Negative EBIT growth while QCOM is at 53.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.38%
Negative operating income growth while QCOM is at 53.33%. Joel Greenblatt would press for urgent turnaround measures.
-20.83%
Negative net income growth while QCOM stands at 50.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.00%
Negative EPS growth while QCOM is at 44.44%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while QCOM is at 44.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-4.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-3.40%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
131.58%
Similar OCF growth to QCOM's 121.84%. Walter Schloss would assume comparable operations or industry factors.
319.57%
FCF growth above 1.5x QCOM's 105.56%. David Dodd would verify if the firm’s strategic investments yield superior returns.
59.17%
10Y revenue/share CAGR under 50% of QCOM's 162.07%. Michael Burry would suspect a lasting competitive disadvantage.
38.19%
5Y revenue/share CAGR under 50% of QCOM's 162.07%. Michael Burry would suspect a significant competitive gap or product weakness.
13.96%
3Y revenue/share CAGR under 50% of QCOM's 162.07%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
168.99%
10Y net income/share CAGR of 168.99% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
5.29%
Net income/share CAGR of 5.29% while QCOM is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-18.74%
Negative 3Y CAGR while QCOM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.02%
Negative 3Y equity/share growth while QCOM is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
70.37%
Dividend/share CAGR of 70.37% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
70.37%
3Y dividend/share CAGR of 70.37% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-2.63%
Firm’s AR is declining while QCOM shows 1.64%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.72%
Inventory is declining while QCOM stands at 15.79%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.81%
Asset growth at 50-75% of QCOM's 2.50%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
7.09%
50-75% of QCOM's 12.95%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.06%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
4.36%
SG&A declining or stable vs. QCOM's 19.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.